Blood Gas Testing Moves Closer to the Bedside

Blood gas results may be needed while a patient is being managed in an emergency department, operating room or intensive care unit. Placing an analyzer near that care area can change how quickly a sample reaches a device. Yet proximity alone does not guarantee that a result will be reliable or reach the right clinician. A point-of-care testing program needs the same attention to patient identity, specimen quality, operator competence and quality management as any other clinical testing service.

The strategic question for a hospital is where a test should be performed. A central laboratory may already provide established processes and trained staff. A bedside or near-patient system may offer a shorter specimen journey for selected situations, but introduces operators, consumables and oversight outside the laboratory. The appropriate balance depends on case mix, hours of operation, transport time, staffing and the availability of a robust central service.

The World Health Organization includes both laboratory and point-of-care tests in its work on essential in vitro diagnostics. Selection is tied to health needs and the level at which a test will be used. For a hospital, that principle means defining the decision a blood gas result will support before buying a machine for a particular ward.

Draw the complete testing route

Start with the clinical request. Who decides a test is indicated? Who collects the specimen and identifies the patient? Where and how is it transported or tested? Who checks that quality control is acceptable? How is the result recorded, communicated and acted upon? A device located close to the patient shortens one leg of the route but leaves the other steps intact.

Pre-analytical issues are especially important because a fast analyzer cannot correct a mislabeled or unsuitable specimen. The team should follow the instructions for the specific test system and establish collection, mixing, timing and handling procedures appropriate to the intended sample. Staff need a clear process for recognizing a rejected sample and obtaining a new one when required.

The US CDC's point-of-care testing training stresses correctly identified specimens, operator responsibilities, safe testing, recording and reporting. Although that particular course addresses waived testing in the US, its underlying workflow questions are useful to ask in other settings; local regulatory rules and the analyzer's own instructions still govern implementation.

Define who owns quality

Point-of-care testing often involves clinicians or nurses who are not laboratory staff. That does not remove the need for laboratory oversight. The hospital should assign responsibility for operator training, competency checks, quality control, instrument maintenance, cartridge inventory and review of problems. Without a named owner, a bedside device can gradually become a set of informal practices that vary between shifts.

Quality control procedures must follow the actual device's instructions and applicable local standards. Staff need to know when control checks are due, what constitutes an unacceptable result and whether patient testing must pause until an issue is resolved. Records should show lot numbers, expiration dates and corrective action when appropriate. A built-in check is not a substitute for patient identification or good specimen collection.

The WHO laboratory quality management handbook

offers a broader framework covering personnel, equipment, purchasing, process control and information. Those areas remain relevant when testing is distributed across several clinical locations. A central laboratory can help develop consistent procedures and monitor performance across all point-of-care sites.

Compare cartridges and service as well as analyzers

The YSENMED blood gas analyzer and POCT collection includes several configurations. A buyer should first confirm the exact parameters that clinicians require and the approved sample types for each model. Product families can differ in cartridge design, test menu, calibration, storage conditions, battery operation and connections to a laboratory information system.

The price of the analyzer is only one cost. Estimate cartridges or test consumables over the expected volume, as well as controls, training, maintenance, waste and shipping. Look carefully at the shelf life of supplies and the minimum order quantity. A low-volume site may waste stock if it buys more cartridges than it can use before expiration; a high-volume site may need stronger supply arrangements and backup capacity.

Storage and transport conditions also matter for an exporter and overseas hospital. The facility should obtain the model-specific requirements and check that they can be maintained during shipping and in local storage. Do not assume that a product's advertised shelf life applies under every temperature condition or after a pack is opened. Confirm how damaged, expired or out-of-control cartridges will be handled.

If the system includes a battery, review how long it supports the expected workload, how charging is managed and how a failure is signaled. A compact machine may be portable yet still depend on a predictable supply of cartridges, controls and printer paper or network access. The full operational package is more meaningful than the size of the analyzer alone.

Make results visible in the clinical record

A handwritten or manually transcribed result creates another opportunity for error. Hospitals considering distributed testing should determine how patient identifiers and results will move into their records. Does the quoted device support a compatible interface, and which options are actually included? Can the system identify the operator and the testing location? What happens when the network is unavailable?

These questions can be tested before full deployment. A pilot with the local laboratory, IT team and clinical users can trace several mock samples from order to documented result. The team can then check that units, reference information, timestamps and patient identifiers appear as intended. A supplier's statement that the device is “LIS compatible” should be followed by a technical review with the actual hospital system.

Clinical staff also need a policy for results that do not fit the patient's condition or conflict with another measurement. Such cases should trigger the facility's established verification and escalation process. The analyzer provides information; trained professionals remain responsible for interpreting it within the patient's care.

Decide where testing adds value

A hospital may choose one analyzer in an emergency unit, a small fleet in several departments or a central laboratory arrangement with rapid specimen transport. No single layout suits every institution. Mapping order-to-result time, patient volume and staffing can reveal whether a near-patient device addresses a real bottleneck. It can also show when better sample transport or laboratory hours would be a more sensible first investment.

YSENMED's POCT equipment range can be considered alongside its broader laboratory solution. The supplier discussion should include intended parameters, daily and peak test numbers, operator locations, quality responsibilities, connectivity, consumables and service arrangements. A detailed request makes it easier to compare configurations and identify what the hospital needs to prepare before installation.

For a staged implementation, the hospital can begin with one department and define what success would look like before expanding. Useful measures include completed operator training, acceptable quality-control performance, cartridge wastage, instrument downtime and the proportion of results correctly transferred to the clinical record. Turnaround time should be measured from the clinical request to an available, usable result rather than from insertion of the sample into the analyzer. This distinction can reveal delays in collection or communication that another device would not solve. The pilot should also examine work outside normal hours, when staffing and technical support may differ from daytime conditions.

Near-patient blood gas testing is an operational choice as much as an equipment choice. Its value comes from a dependable path between a justified request and an interpretable result. Hospitals that plan specimens, people, quality control, supplies and information together can assess that value realistically—and select devices that fit the service they intend to run.